Virtual Medicinal Product (VMP)
-
Canakinumab 150mg powder for solution for injection vials
Name Details
|
Current Name
Canakinumab 150mg powder for solution for injection vials
|
Start Date
04-01-2010
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Caution - AMP level prescribing advised
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Powder for solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L04AC08
| BNF |
|
Current BNF
08020400
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
08020400
|
Start Date
05-11-2010
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 16592911000001100 |
04-01-2010 |
|
VMP Ingredients
VMP ingredients table
| Canakinumab |
Based on Ingredient Substance |
|
150 mg |
|
Name
Canakinumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Canakinumab
-
VMP
(Current) Canakinumab 150mg powder for solutio...
Virtual Medicinal Product Pack (VMPP) Information